Benzimidazoles and their use for the treatment of diabetes

Details for Australian Patent Application No. 2007255180 (hide)

Owner AstraZeneca AB

Inventors Birch, Alan Martin; Butlin, Roger John; Plowright, Alleyn

Agent Davies Collison Cave

Pub. Number AU-B-2007255180

PCT Pub. Number WO2007/141517

Priority 60/811,895 08.06.06 US

Filing date 6 June 2007

Wipo publication date 13 December 2007

Acceptance publication date 3 February 2011

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2007/141517 Priority application(s): WO2007/141517

2 April 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Benzimidazoles and their use for the treatment of diabetes

3 February 2011 Application Accepted

  Published as AU-B-2007255180

2 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007255184-Apparatus, assembly and method of forming a decorative feature on a structure

2007255176-Use of coumarin derivatives in antifungal therapy